Anakinra for haemophagocytic lymphohistiocytosis for adults and children in all ages

Document first published:
Page updated:
Topic:
, ,
Publication type:

Anakinra is recommended to be available as a treatment option for adults and children of all ages through routine commissioning for haemophagocytic lymphohistiocytosis within the criteria set out in this document. In England services will be commissioned through specialised rheumatology networks.